Abstract
Cbl-b, a mammalian homolog of Cbl, consists of an N-terminal region (Cbl-b-N) highly homologous to oncogenic v-Cbl, a Ring finger, and a C-terminal region containing multiple proline-rich stretches and potential tyrosine phosphorylation sites. In the present study, we demonstrate that upon engagement of the T cell receptor (TCR), endogenous Cbl-b becomes rapidly tyrosine-phosphorylated. In heterogeneous COS-1 cells, Cbl-b was phosphorylated on tyrosine residues by both Syk- (Syk/Zap-70) and Src- (Fyn/Lck) family kinases, with Syk kinase inducing the most prominent effect. Syk associates and phosphorylates Cbl-b in Jurkat T cells. A Tyr-316 Cbl-binding site in Syk was required for the association with and for the maximal tyrosine phosphorylation of Cbl-b. Mutation at a loss-of-function site (Gly-298) in Cbl-b-N disrupts its interaction with Syk. Cbl-b constitutively binds Grb2 and becomes associated with Crk-L upon TCR stimulation. The Grb2- and the Crk-L-binding regions were mapped to the C-terminus of Cbl-b. The Crk-L-binding sites were further determined to be Y655DVP and Y709KIP, with the latter being the primary binding site. Taken together, these results implicate that Cbl-b is involved in TCR-mediated intracellular signaling pathways.
Similar content being viewed by others
References
Andoniou CE, Thien CB and Langdon WY. . 1996 Oncogene 12: 1981–1989.
Blake TJ, Shapiro M, Morse HCd and Langdon WY. . 1991 Oncogene 6: 653–657.
Bonnefoy BN, Liu Y-C, von WM, Sung A, Elly C, Mustelin T, Yoshida H, Ishizaka K and Altman A. . 1995 Proc. Natl. Acad. Sci. USA 92: 10142–10146.
Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL and Nadler LM. . 1997 Science 278: 124–128.
Bustelo XR, Crespo P, Lopez BM, Gutkind JS and Barbacid M. . 1997 Oncogene 15: 2511–2520.
Deckert M, Elly C, Altman A and Liu Y-C. . 1998 J. Biol. Chem. 273: 8867–8874.
Donovan JA, Ota Y, Langdon WY and Samelson LE. . 1996 J. Biol. Chem. 271: 26369–26374.
Donovan JA, Wange RL, Langdon WY and Samelson LE. . 1994 J. Biol. Chem. 269: 22921–22924.
Feshchenko EA, Langdon WY and Tsygankov AY. . 1998 J. Biol. Chem. 273: 8323–8331.
Fournel M, Davidson D, Weil R and Veillette A. . 1996 J. Exp. Med. 183: 301–306.
Keane MM, Rivero Lezcano OM, Mitchell JA, Robbins KC and Lipkowitz S. . 1995 Oncogene 10: 2367–2377.
Kong G, Dalton M, Wardenburg JB, Straus D, Kurosaki T and Chan A. . 1996 Mol. Cell. Biol. 16: 5026–5035.
Langdon WY, Hartley JW, Klinken SP, Ruscetti SK and Morse HCd. . 1989 Proc. Natl. Acad. Sci. USA 86: 1168–1172.
Latour S, Chow L and Veillette A. . 1996 J. Biol. Chem. 271: 22782–22790.
Lavagna-Sevenier C, Marhetto S, Birnbaum D and Rosnet O. . 1998 J. Biol. Chem. 273: 14962–14967.
Liu Y-C and Altman A. . 1998 Cell Signaling 10: 377–385.
Liu Y-C, Elly C, Langdon WY and Altman A. . 1997a J. Biol. Chem. 272: 168–173.
Liu Y-C, Liu Y, Elly C, Yoshida H, Lipkowitz S and Altman A. . 1997b J. Biol. Chem. 272: 9979–9985.
Liu Y-C, Elly C, Yoshida H, Bonnefoy-Berard N and Altman A. . 1996 J. Biol. Chem. 271: 14591–14595.
Lupher ML, Songyang Z, Shoelson SE, Cantley LC and Band H. . 1997 J. Biol. Chem. 272: 33140–33144.
Lupher MLJ, Reedquist KA, Miyake S, Langdon WY and Band H. . 1996 J. Biol. Chem. 271: 24063–24068.
Marengere L, Mirtsos C, Kozieradzki I, Veillette A, Mak T and Penninger J. . 1997 J. Immunol. 159: 70–76.
Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CB, Landon W and Bowtell D. . 1998 Mol. Cell. Biol. 18: 4872–4882.
Ota Y, Beitz LO, Scharenberg AM, Donovan JA, Kinet JP and Samelson LE. . 1996 J. Exp. Med. 184: 1713–1723.
Ota Y and Samelson LE. . 1997 Science 276: 418–420.
Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ and Band H. . 1996 J. Biol. Chem. 271: 8435–8442.
Rellahan BL, Graham LJ, Stoica B, DeBell KE and Bonvini E. . 1997 J. Biol. Chem. 272: 30806–30811.
Tanaka S, Ouchi T and Hanafusa H. . 1997 Proc. Natl. Acad. Sci. USA 94: 2356–2361.
Wange RL and Samelson LE. . 1996 Immunity 5: 197–205.
Weiss A and Littman DR. . 1994 Cell 76: 263–274.
Williams BL, Schreiber KL, Zhang W, Wange RL, Samelson LE, Leibson PJ and Abraham RT. . 1998 Mol. Cell. Biol. 18: 1388–1399.
Zhang Z, Elly C, Altman A and Liu Y-C. . 1998 Submitted for publication.
Zhao Q and Weiss A. . 1996 Mol. Cell. Biol. 16: 6765–6774.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elly, C., Witte, S., Zhang, Z. et al. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene 18, 1147–1156 (1999). https://doi.org/10.1038/sj.onc.1202411
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202411
- Springer Nature Limited
Keywords
This article is cited by
-
Umbilical mesenchymal stem cell-derived exosomes facilitate spinal cord functional recovery through the miR-199a-3p/145-5p-mediated NGF/TrkA signaling pathway in rats
Stem Cell Research & Therapy (2021)
-
Accessory proteins of the RAS-MAPK pathway: moving from the side line to the front line
Communications Biology (2021)
-
Cbl-b in T-cell activation
Seminars in Immunopathology (2010)
-
Syk
AfCS-Nature Molecule Pages (2007)
-
Molecular mechanisms of CD4+ T-cell anergy
Nature Reviews Immunology (2007)